Trillium Therapeutics Inc. Stock News

Two sample Breakout Stocks for Week 52 with better than 10% short-term upside potential and a Dow stock pick. This past week, two stocks beat 10% peak gains in FLGT +19.1% and DYAI +13.8% with Momentu

Two sample Breakout Stocks for Week 51 with better than 10% short-term upside potential. The ETF/ETN forecast section now goes out in a separate article. This past week, 1 stock beat 10% peak gains in

Two sample Breakout Stocks for Week 50 with better than 10% short-term upside potential. The ETF/ETN forecast section now goes out in a separate article. This past week 1 stock beat 10% peak gains in

Two sample Breakout Stocks for Week 49 with better than 10% short-term upside potential. The ETF/ETN forecast section now goes out in a separate article. This past week 2 stocks beat 10% peak gains wi

Two sample Breakout Stocks for Week 48 with better than 10% short-term upside potential. The ETF/ETN forecast section now goes out in a separate article. Following the Daily Momentum Gauges® the port

Trillium Therapeutics (NASDAQ:TRIL) (TSE:TR) was downgraded by investment analysts at Benchmark from a “buy” rating to a “hold” rating in a report released on Wednesday, The Fly reports. Other equities analysts also recently issued research reports about the company. Bloom Burton began coverage on Trillium Therapeutics in a report on Friday, October 1st. They issued […]

Trillium Therapeutics Inc. (NASDAQ:TRIL) price is hovering higher on Tuesday, November 16, jumping 2.64% above its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy

Trillium Therapeutics Inc. (NASDAQ:TRIL) (TSE:TR) shares saw unusually-strong trading volume on Tuesday . Approximately 661,216 shares were traded during trading, a decline of 62% from the previous sessions volume of 1,755,849 shares.The stock last traded at $18.39 and had previously closed at $17.97. A number of equities research analysts recently commented on TRIL shares. Craig []

Trillium Therapeutics Inc. (TSE:TRIL) shares were up 0.1% during trading on Monday . The stock traded as high as C$22.48 and last traded at C$22.47. Approximately 35,356 shares were traded during mid-day trading, a decline of 79% from the average daily volume of 166,789 shares. The stock had previously closed at C$22.45. Separately, Bloom Burton []

ARCE, NSSC, PAGP, TRIL, and VALE have been added to the Zacks Rank #5 (Strong Sell) List on September 15, 2021.

Moderna has been getting all of the attention, but Pfizer is a complete package that might be a better buy.

This deal checks off several boxes for Pfizer.

Investors could easily tap the bullish trend by considering a near-term long on the biotech sector.